AfterRaise/Companies/Expedition Therapeutics

Expedition Therapeutics

USASan FranciscoBiotech & PharmaSeries B

Overview

Where Expedition Therapeutics is now

Expedition Therapeutics announced a Series B round of $115M on 5 August 2026, led by General Atlantic.

Observed Described in the funding announcement as "clinical-stage biotechnology platform". Source

Latest round
Series B
Amount
$115M
Announced
5 August 2026
Headquarters
San Francisco, USA
Sector
Biotech & Pharma
Investors
General Atlantic
Also participating
RA Capital, Vivo Capital, Sofinnova Investments, Novo Holdings, Forbion, Dawn Biopharma, Adage Capital Management, Balyasny Asset Management, Logos Capital, Sanofi Ventures, BVF Partners, and Venrock Healthcare Capital Partners
Relevant leadership
Founder and CEO Yi Larson

Current direction Inferred

What this company is working on

Market expansionProductResearch and development

Read from the company's own description of what the funding supports.

Momentum Inferred

AfterRaise Score

80
High momentum
1 funding signal in the last 90 days
Funding recency
40/40
announced within the last 30 days
Round scale
22/25
round size relative to the market
Funding stage
18/20
Series B
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Growth timeline

What has happened so far

  • 5 August 2026
    $115M Series B
    Led by General Atlantic.

Observed The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

Moves

Published by the company

Share a Move

No company-published Moves yet

AfterRaise has the funding facts for Expedition Therapeutics from public sources. What it does not have is what the company is doing next, in the company's own words. That part only they can write.

Work here? Publish the first Move

Opportunities

Work this company has opened

No open Opportunities listed

Jobs, projects, partnerships and advisory needs appear here once the company has claimed its room and published them.

Work here? Open the first one

Open to

Who may approach Expedition Therapeutics

Not yet specified

Expedition Therapeutics has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Work here?

This room belongs to Expedition Therapeutics.

Claim it to publish Moves in your own words, open Opportunities, choose who may approach you, and see the offers of help you have received. Everything you publish is reviewed before it appears.

Also moving

Other Biotech & Pharma companies

See the sector